{"id":"phanquinone","rwe":[],"tags":[{"label":"phanquinone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"P01AX04","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"entobex","offLabel":[],"synonyms":["phanquinone","enthobex","entobex","entronon","phanchinone","phanquinonum","phanquone"],"timeline":[],"approvals":[],"brandName":"Entobex","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phanquinone","explanation":"Think of Entobex like a key that fits into a lock on a cell. When it binds to the lock, it triggers a series of events that ultimately lead to the desired outcome. However, the exact details of how Entobex interacts with its target are still not well understood.","oneSentence":"Entobex works by interacting with a specific cellular target to produce its therapeutic effects.","technicalDetail":"As a phanquinone, Entobex is a type of quinone compound that may exert its effects through redox reactions or other mechanisms involving electron transfer."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3433","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=phanquinone","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:17:45.976987","biosimilars":[],"competitors":[{"drugName":"atovaquone","drugSlug":"atovaquone","fdaApproval":"1992-11-25","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trimetrexate","drugSlug":"trimetrexate","fdaApproval":"1993-12-17","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"nitazoxanide","drugSlug":"nitazoxanide","fdaApproval":"2002-11-22","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"phanquinone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"atovaquone","brandName":"atovaquone","genericName":"atovaquone","approvalYear":"1992","relationship":"same-class"},{"drugId":"trimetrexate","brandName":"trimetrexate","genericName":"trimetrexate","approvalYear":"1993","relationship":"same-class"},{"drugId":"nitazoxanide","brandName":"nitazoxanide","genericName":"nitazoxanide","approvalYear":"2002","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"ID94IS6N8J","CHEBI":"CHEBI:59141","INN_ID":"924","UMLSCUI":"C0070517","ChEMBL_ID":"CHEMBL531048","KEGG_DRUG":"D07359","DRUGBANK_ID":"DB13469","PUBCHEM_CID":"6764","MESH_SUPPLEMENTAL_RECORD_UI":"C004902"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"P01AX04","allCodes":["P01AX04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Entobex, also known as phanquinone, is a small molecule drug in the phanquinone class. Its exact target and mechanism of action are unknown, but it is being developed for potential therapeutic applications. The commercial status of Entobex is unclear, and it is not yet FDA-approved for any indications. Further research is needed to determine its efficacy and safety profile. As a result, Entobex is not yet available as a generic medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}